Kausik Ray MD FMedSci/LinkedIn
Nov 1, 2025, 05:15
Kausik Ray Celebrates MENA Launch of ACLY Inhibitor
Kausik Ray, Professor of Public Health at Imperial College London, Past President of European Atherosclerosis Society, posted on LinkedIn:
”One of the exciting things I have had the honoring of doing over the years are launch meetings. Bringing new therapies from the first PCSK9 MAbs, then to the first siRNA inclisiran and now the first ACLY inhibitor Bempedoic acid in the MENA region.
Good discussions about the CVD, lipids, guidelines and where new therapies sit in this this region at high risk for CVD.
The last 15 years of time spent on education, awareness, simplicity continue to help bring improvements in patient care.”
Stay informed with Hemostasis Today.
-
Aug 21, 2026, 14:32Kenneth Nollet: Building the Future of Transfusion Laboratory Science
-
Aug 21, 2026, 14:14Tareq Abadl: A Positive Antibody Screen is Not The Diagnosis
-
Aug 21, 2026, 14:08Katrina Snow։ Transfusion Trends and Quality Improvement in Sickle Cell Disease
-
Aug 21, 2026, 14:00Rucha Patil: The Power of Point-of-Care Testing in Hemostasis
-
Aug 21, 2026, 13:56Sarah Kowalski։ Supporting the Next Generation of Transfusion Laboratory Scientists
-
Aug 21, 2026, 13:51Join EHC 2026 Annual Conference
-
Aug 21, 2026, 12:57David McIntosh: Why Do Blood Supplies Still Fall Short?
-
Aug 21, 2026, 12:48Joshua Penrod: 35 Years of Progress in Plasma Safety
-
Aug 21, 2026, 12:42Moustafa Abdou: Diagnosis and Management of Pyruvate Kinase Deficiency